LLMs for Atrial Fibrillation Patient Education: Cardiologist vs. Non-Medical Professional Perceptions of ChatGPT and Google Gemini Quality
What the Researchers Tested
This pilot study employed a straightforward comparative analysis design. The core methodology involved submitting a standardized clinical prompt, "Explain atrial fibrillation and how to treat it to a patient," to two prominent large language models (LLMs): ChatGPT and Google Gemini. The generated text responses were then disseminated to a diverse participant group via a Google Forms survey. The survey instrument was meticulously crafted, incorporating items derived from established tools for assessing patient education materials, specifically the Patient Education Materials Assessment Tool for Printable Materials (PEMAT-P) and the DISCERN criteria. These criteria encompass aspects such as reliability, clarity, and organizational structure. Participant evaluation involved rating each aspect on a 5-point Likert scale. The study cohort consisted of 28 individuals, segmented into two distinct groups: medical professionals (cardiologists and cardiology fellows, n=11) and non-medical professionals (college graduates not employed in the medical field, n=17). Statistical analysis, utilizing the Wilcoxon signed-rank test, was performed to compare mean ratings for various quality indicators between the two AI platforms and across the different participant groups, thereby identifying significant perceptual differences in the assessment of AI-generated educational content.
What the Study Found
No significant overall quality differences were observed between ChatGPT and Google Gemini for explaining atrial fibrillation and its treatment to patients.
Cardiologists rated AI-generated responses significantly higher than non-medical professionals for perceived bias (mean 3.82 vs mean 4.33; P=.04).
Cardiologists rated AI-generated responses significantly higher for explaining consequences of no treatment (mean 2.85 vs mean 1.86; P=.005) compared to non-medical professionals.
Non-medical professionals rated structural and organizational features more favorably than cardiologists, including visual cues (mean 3.97 vs mean 2.48; P<.001), informative headers (mean 4.77 vs mean 3.95; P=.001), and concise sections (mean 4.71 vs mean 4.29; P=.04).
Non-medical professionals also rated identifiable patient actions (mean 4.21 vs mean 3.19; P=.04) and references to additional resources (mean 2.65 vs mean 1.71; P=.006) more favorably than cardiologists.
Why This Matters to Clinical Practice
The increasing integration of AI into healthcare necessitates a rigorous evaluation of its utility, particularly in patient education. Accurate and comprehensible patient understanding of conditions like atrial fibrillation is paramount for adherence to treatment, lifestyle modifications, and early recognition of complications such as stroke and heart failure. LLMs offer a scalable and accessible means to disseminate health information, but their efficacy hinges on the quality and contextual appropriateness of their output. This study highlights a critical disconnect: what medical experts deem 'quality' in health information (e.g., accuracy, bias, consequence explanation) differs substantially from what laypersons prioritize (e.g., structural clarity, visual aids). For practicing clinicians and department heads, these findings underscore the importance of not solely relying on AI-generated content without clinical oversight and customization. While LLMs can provide a foundational draft for patient education, specialists must critically review and adapt such materials to ensure accuracy, address potential biases, and frame information in a way that resonates with patient learning styles and priorities. Overlooking these nuanced differences could lead to suboptimal patient comprehension, reduced adherence, and potentially adverse health outcomes, thereby undermining the very goal of leveraging AI for improved patient engagement.
Clinical & Workflow Takeaways
Clinicians, particularly cardiologists and those involved in patient education, should view AI-generated content as a starting point rather than a final product for patient materials. While LLMs can efficiently produce initial drafts, a thorough review is crucial to ensure clinical accuracy, unbiased presentation, and clear articulation of treatment consequences. When developing patient education resources, it is advisable to involve both clinical experts and patient representatives (or those with similar non-medical backgrounds) in the review process. This multidisciplinary approach can help balance clinical rigor with user-friendliness, addressing both the informational needs identified by medical professionals and the structural preferences highlighted by non-medical individuals. Department heads should consider implementing guidelines for the use of AI in patient education, advocating for human-in-the-loop validation to maintain high standards of patient communication and mitigate potential misunderstandings.
Limitations and What Remains Uncertain
This was a pilot study with a relatively small sample size (n=28), which limits the generalizability of the findings. The evaluation was based on a single prompt and specific versions of the AI models (ChatGPT and Google Gemini), meaning results may not apply to other LLMs, different prompts, or future iterations of these platforms. The assessment relied on self-reported perceptions via a Likert scale, which can be subjective. Furthermore, the study did not evaluate the actual impact of these AI explanations on patient comprehension, retention, or clinical outcomes, focusing solely on perceived quality. Future research needs to involve larger, more diverse cohorts and longitudinal studies to assess real-world efficacy and long-term effects on patient behavior and health status.
Explore the Work Behind Clinical AI
MedXchange Research Fellowship
Publish Clinical AI Research With Us
Our 10-week fellowship mentors physicians and researchers to build foundation models, analyze multimodal health datasets, and co-author peer-reviewed clinical studies.
Related Clinical AI Stories
AI Chatbot Performance in Orthopedic Education: GPT-4o Outperforms AAOS Members in Adult Reconstruction
A recent study published in the Rhode Island Medical Journal evaluated the performance of seven contemporary AI chatbots on 55 multiple-choice questions from the AAOS ResStudy question bank, focusing on adult reconstruction. The objective was to assess the accuracy, response time, and citation reliability of these AI models when confronted with clinically oriented orthopedic questions. Overall, the chatbots achieved a moderate accuracy of 67.5%, with significant variability among models and question types. Notably, GPT-4o demonstrated the highest accuracy at 80%, surpassing the average performance of AAOS members, who scored 75% on the same questions. Co-Pilot secured the second-best performance at 70.9%. The study meticulously categorized questions by anatomic region, concept (clinical presentation, prognosis, management), and AAOS-defined difficulty, revealing that AI chatbots excelled in descriptive knowledge (Clinical Presentation) but struggled with complex applied reasoning, such as prognosis and management. The findings suggest a valuable supplementary role for AI in orthopedic education, while highlighting areas needing further development.
Rifamycin MMX Shows Minimal Impact on Gut Resistome in Cirrhosis, Trends Towards Reduced Vancomycin Resistance
A double-blind, placebo-controlled clinical trial, RIVET, investigated the effects of rifamycin SV MMX (RiVM) on gut microbial antibiotic resistance genes (ARGs) in patients with compensated cirrhosis. Given that ARG carriage is linked to poorer outcomes in cirrhosis, and prior preclinical data suggested rifaximin might expand ARGs, this study aimed to clarify RiVM's impact. The trial involved 30 patients (15 RiVM, 15 placebo) who underwent shotgun metagenomic sequencing before and after 30 days of therapy. Key findings indicate that RiVM induced minimal perturbation of the gut resistome, showing no significant increase in ARGs compared to placebo after false discovery rate (FDR) adjustment. Intriguingly, there was a trend towards reduced vancomycin resistance-associated ARGs, specifically vanW and vanT operon-associated genes, post-RiVM exposure. While some Enterobacteriaceae-associated multidrug efflux regulators (e.g., evgS, emrK, mdtA) nominally increased, these did not sustain significance after FDR correction. The study concluded that RiVM did not enrich antimicrobial resistance genes or lead to increased infections over 30 days in this patient cohort.
AI in Precision Psychiatry: Navigating Biomarker Discovery from Concept to Clinic
The field of psychiatric biomarker discovery has long been hampered by challenges including suboptimal phenotypic characterization and limited cohort sizes. Recent advancements in artificial intelligence (AI), particularly large language models (LLMs) and self-supervised learning, are poised to revolutionize this landscape by transforming vast amounts of unstructured clinical text into quantifiable data and extracting insights from routinely collected, unlabeled psychiatric signals. This review highlights AI's role in the early stages of biomarker identification, from molecular interpretation to candidate generation. While AI demonstrates significant potential in identifying novel psychiatric biomarkers, a critical gap remains between computational discovery and clinical utility. The review emphasizes an inherent asymmetry: AI can rapidly generate biomarker candidates, but the rigorous, costly process of clinical validation for real-world application remains largely unaddressed by AI itself. The authors propose a structured, six-stage framework to bridge this gap, delineating the journey from intended clinical use and measurement validity to model evaluation, comparative utility, and ultimately, monitored deployment. This framework clarifies where AI can accelerate discovery and where traditional clinical validation is indispensable.